Toxicology

<p>Applications Phthalamic Acid is a reactant in the synthesis of phthalimide derivatives with analgesic activity.<br>References Gajare, S.P., Mahajan, S.S.: Int. J. Pharmaceut. Phytopharmacol. Res., 1, 357 (2012)<br></p>

<p>Applications Diclofenac Potassium Salt is a nonsteroidal anti-inflammatory compound an decycloxygenase (COX) inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kenny, J. R., et al.: J. Med. Chem., 47, 2816 (2004), Sasaki, A., et al.: J. Pharmacol. Sci., 108, 266 (2008), Dalvie, D., et al.: Chem. Res. Toxicol., 22, 357 (2009),<br></p>

<p>Stability Hygroscopic, Temperature Sensitive<br>Applications Amoxicillin trimer Trisodium Salt, is an impurity of Amoxicillin (A634235), a β-lactam family antibiotic that is commonly used in conjunction with clavulanic acid (C56370) to the treat bacterial infections.<br>References Gurwith, M., et al.: Antimicrob. Agents Ch., 24, 716 (1983); Kumar, A., et al.: J. Mater. Chem., 20, 10152 (2010);<br></p>

<p>Applications ((2S,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate is an intermediate in the synthesis of Itraconazole (I937500), an orally active antimycotic structurally related to Ketoconazole. Antifungal.<br>References Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989), Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993)<br></p>

<p>Applications Methyl Oleate can be used as a plasticizer. It is one of the biodiesel constituent fluids.<br>References Ben Amara, A., et al.: Energ. Fuel, 27, 6125 (2013); Arca, M., et al.: J. Am. Oil Chem. Soc., 89, 987 (2012)<br></p>

<p>Applications Clindamycin Cyclomonophosphate is a by-product during the synthesis of Clindamycin Phosphatidyl Anhydride (C580110), an impurity of Clindamycin (C580000), which is an antibiotic prepared from Lincomycin (L466200), used to treat various infections.<br>References Birkenmeyer, R.D., et al.: J. Med. Chem., 13, 616 (1970); Oesterling, et al.: J. Pharm. Sci., 59, 63 (1970); Gray, J.E., et al.: Toxicol. Appl. Pharmacol., 21, 516 (1972); Brown, L.W., et al.: Anal. Profiles Drug Subs., 10, 75 (1981)<br></p>

<p>Applications N-demethyl-6-O-methyl-N-[(phenylmethoxy)carbonyl]-, 2'-(phenylmethyl carbonate) Erythromycin is an intermediate in the synthesis of Clarithromycin-N-methyl-13C, d3 (C559754), which is the labeled analogue of Clarithromycin (C559750), which is a semi-synthetic macrolide antibiotic. Clarithromycin is a derivative of Erythromycin (E650000).<br>References Benson, C., et al.: Eur. J. Clin. Microbiol., 6, 173 (1987), Boyanova, L., et al.: J. Med. Microb., 61, 85 (2012), Lin, Z., et al.: Toxicol. Sci., 126, 114 (2012),<br></p>

<p>Applications Used in the preparation of quinolones, benzoxazolones, and benzoxazinones as β agonists for the treatment of respiratory diseases<br></p>

<p>Applications 3-tert-Butyldimethylsilyloxyoleyl O-(Methoxymethoxy)carnitine Ester Chloride Salt is an analog of Carnitine (C184110), an essential cofactor for the metabolism of fatty acids.<br></p>

<p>Applications (R)-(-)-2,2-Dimethyl-1,3-dioxolan-4-ylmethyl p-Toluenesulfonate is a chiral building block. It is used to prepare the antifungal agent ketoconazole. It is also used to prepare acyclic Nucleotide Analogs Derived from 8-Azapurines with antiviral activities.<br>References Rotstein, D., et al.: J. Med. Chem., 35, 2818 (1992); Holy, A., et al.: J. Med. Chem., 39, 4073 (1996)<br></p>

<p>Applications 2-Chloro-5-(trifluoromethyl)pyridine is a starting material for the preparation of novel herbicide fluazifop-butyi. 2-Chloro-5-(trifluoromethyl)pyridine is a mutagenic compound.<br>References Lu, Y., et al.: Shijie Nongyao, 31, 32 (2009); Dearfield, K. L., et al.: Mutat. Res. Lett., 301, 57 (1993)<br></p>

<p>Applications 4-Chlororesorcinol-d3 is a labeled analogue of 4-Chlororesorcinol (C427755), which can be used as hair dye formulation, and in the synthesis of series of six coumarin compounds carrying halogen and trifluoromethyl, having antifungal activities.<br>References Hui-juan, Zh., et al.: Huanjing Yu Jiankang Zazhi, 27, 513 (2010); Hai-yun, Xh., et al.: Baoji Wenli Xueyuan Xuebao, Ziran Kexueban, 31, 12 (2011)<br></p>

<p>Applications (9Z)-Erythromycin A Oxime is a metabolite of Roxithromycin (R700850) in humans.<br>References Zhong, D. et al.: Drug Metab. Dispos., 28, 552 (2000)<br></p>

<p>Applications 3,4-Dihydroxyphenylacetic Acid Methyl Ester is a biogenic amine metabolite. 3,4-Dihydroxyphenylacetic Acid Methyl Ester is used in the preparation of antioxidants and bacteriostatic agents. It is used in the synthesis of noncompetitive AMPA receptor antagonists as benzodiazepines, as well as optically active quinolones with dopaminergic properties.<br>References Verhe, R. et al.: Bull. Lais. Gr. Polyphen., 16, 237 (1992); Anggard, E. et al.: J. Chrom., 50, 251 (1970); Cabedo, N. et al.: J. Med. Chem., 44, 1794 (2001); Zappala, M. et al.: Bioorg. Med. Chem. Lett., 16, 167 (2006);<br></p>